Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

Melatonin solution helps treat hair loss in men and women.

Minoxidil helps treat pattern hair loss in both men and women.

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.

PRP injections improve hair density and thickness in women with hair loss.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Probiotic supplements may help reduce inflammation and oxidative stress in women with PCOS.

Vulvar acne, also known as "vulvar Fordyce adenitis", is a condition causing painful bumps on the labia, and it's not always effectively treated with common acne medications, but isotretinoin has shown promise.

Female pattern hair loss negatively affects quality of life, and treatment does not improve it within two months.

Surgery removed ovarian tumors, normalizing testosterone and improving symptoms.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Low-Level Light Therapy improves quality of life more for women than men with hair loss.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

Iron deficiency is not a significant cause of hair loss in women.

Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.

Low iron levels are strongly linked to chronic hair loss in women.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Tamoxifen caused hair loss in a 52-year-old woman.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

The HSVS-A is an effective tool for quickly screening hair shedding in Asian women.